Page last updated: 2024-08-21

quinazolines and Cardiovascular Stroke

quinazolines has been researched along with Cardiovascular Stroke in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-199022 (56.41)18.7374
1990's0 (0.00)18.2507
2000's8 (20.51)29.6817
2010's9 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harmann, LM; Meyer, J; Petersen, M; Routhu, KV; Sonin, DL; Strande, JL; Wakatsuki, T1
Schaaf, M; Sibellas, F1
Beyer, EC; Dudley, SC; Efimov, IR; Gemel, J; Greener, ID; Liu, H; Ng, FS; Rutledge, CA; Sergeyenko, AM; Sovari, AA; Sulkin, MS1
Birnbaum, Y; Kodakandla, M; Ling, S; Nanhwan, MK; Nylander, S; Ye, Y1
Cai, MX; Chen, T; Du, SJ; Lin, QQ; Shi, XC; Tan, ZN; Tian, ZJ1
Bartha, E; Habon, T; Halmosi, R; Hideg, K; Kálai, T; Kalman, E; Kiss, GN; Kulcsár, G; Sumegi, B; Toth, K1
Vetter, C1
Kickler, TS; Lynch, DR; Rade, JJ1
Beijnen, JH; Lankheet, NA; Malingré, MM; Schaefer-Prokop, CM; Staaks, GH; ter Heine, R; van den Bosch, RT; van den Brand, JJ; van der Westerlaken, MM1
Hocher, B; Klein, T; Mark, M; Pfab, T; Sharkovska, Y1
Johansen, OE; Neubacher, D; Patel, S; von Eynatten, M; Woerle, HJ1
Deng, HW; Hu, CP; Li, NS; Li, YJ; Xiao, L1
Buyniski, JP; Fleming, JS1
Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C1
Kanazawa, S; Kinoshita, Y; Muramatsu, M; Nomura, S; Yamaguchi, K1
Deres, P; Gallyas, F; Halmosi, R; Hanto, K; Hideg, K; Kalai, T; Kulcsar, G; Palfi, A; Sumegi, B; Szabados, E; Szereday, Z; Toth, A; Toth, K1
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J1
Alexandris, AT; Kalogeropoulos, CK; Karlas, EN; Kolettis, MT; Tzannetis, GC1
Kather, H1
Braunwald, E; Colucci, WS; Holman, BL; Wynne, J1
Khomenko, VL; Pomerantsev, VP; Vasiuk, IuA1
Atlas, D; Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D1
Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL1
Amsterdam, EA; Awan, NA; Hermanovich, J; Mason, DT; Vera, Z1
Coma Canella, I; López-Sendón, J1
Bertolasi, CA; Pérez Baliño, N; Riccitelli, MA; Trongé, J; Villamayor, RM1
Bazzino, O; Cremades, E; Doval, H; Oliveri, R1
Mason, DT1
Costa, PP; Croce, G; Fernandes, P; Permutti, B1
Doods, HN; van Zwieten, PA; Wu, DM1
Coma-Canella, I; Jadraque, LM; Lombera, F; Lopez-Sendon, J1
Awan, NA; Mason, DT; Maxwell, KS; Miller, RR1
Conely, JM; Hillis, WS; Hutton, I; Langhan, CE; Lawrie, TD1
Buchanan, JO; Buyniski, JP; Fleming, JS1
Evdokimov, EI; Stets, VR; Tishkin, VS1
Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T1
Abiko, Y; Hara, Y; Ichihara, K1
Parratt, JR; Winslow, E2

Reviews

3 review(s) available for quinazolines and Cardiovascular Stroke

ArticleYear
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 75, Issue:3

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Fatal Outcome; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Myocardial Infarction; Pleural Neoplasms; Protein Kinase Inhibitors; Quinazolines

2012
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.
    Cardiovascular diabetology, 2012, Jan-10, Volume: 11

    Topics: Aged; Angina, Unstable; Biomarkers; Blood Glucose; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Evidence-Based Medicine; Female; Glycated Hemoglobin; Hospitalization; Humans; Linagliptin; Male; Middle Aged; Myocardial Infarction; Patient Safety; Proportional Hazards Models; Prospective Studies; Purines; Quinazolines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Treatment Outcome

2012
[Peripheral vasodilator agents in cardiology].
    Sovetskaia meditsina, 1980, Issue:12

    Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents

1980

Trials

3 trial(s) available for quinazolines and Cardiovascular Stroke

ArticleYear
Long-term therapy of heart failure with prazosin: a randomized double blind trial.
    The American journal of cardiology, 1980, Volume: 45, Issue:2

    Topics: Adult; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Placebos; Prazosin; Quinazolines; Radionuclide Imaging; Renin

1980
[Peripheral vasodilator agents in cardiology].
    Sovetskaia meditsina, 1980, Issue:12

    Topics: Clinical Trials as Topic; Coronary Vessels; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Nitrates; Nitroglycerin; Nitroprusside; Phentolamine; Piperazines; Prazosin; Quinazolines; Vasodilator Agents

1980
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
    Circulation, 1982, Volume: 65, Issue:4

    Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines

1982

Other Studies

34 other study(ies) available for quinazolines and Cardiovascular Stroke

ArticleYear
Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.
    Journal of cardiovascular pharmacology and therapeutics, 2013, Volume: 18, Issue:5

    Topics: Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Imaging, Three-Dimensional; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Transforming Growth Factor beta; Ventricular Remodeling

2013
Acute myocardial infarction and anagrelide.
    International journal of cardiology, 2013, Sep-30, Volume: 168, Issue:2

    Topics: Adult; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Quinazolines

2013
c-Src kinase inhibition reduces arrhythmia inducibility and connexin43 dysregulation after myocardial infarction.
    Journal of the American College of Cardiology, 2014, Mar-11, Volume: 63, Issue:9

    Topics: Animals; Arrhythmias, Cardiac; Benzodioxoles; Connexin 43; CSK Tyrosine-Protein Kinase; Death, Sudden; Echocardiography; Enzyme Inhibitors; Gap Junctions; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Protein Phosphatase 1; Quinazolines; Reactive Oxygen Species; src-Family Kinases

2014
Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
    Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:9

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Aspirin; Cardiotonic Agents; Clopidogrel; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Enzyme Induction; Lipoxins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Pyrazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Ticagrelor; Ticlopidine; Triazoles; Up-Regulation

2014
Exercise training activates neuregulin 1/ErbB signaling and promotes cardiac repair in a rat myocardial infarction model.
    Life sciences, 2016, Mar-15, Volume: 149

    Topics: Animals; Disease Models, Animal; Male; Myocardial Infarction; Neuregulin-1; Oncogene Proteins v-erbB; Physical Conditioning, Animal; Quinazolines; Rats; Rats, Sprague-Dawley; Tyrphostins

2016
Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Journal of cardiovascular pharmacology, 2008, Volume: 52, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Disease Models, Animal; Echocardiography; Enalapril; Enzyme Inhibitors; Fibrosis; Heart Failure; Male; Myocardial Infarction; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling

2008
[Migraine can signal a risk for heart and brain].
    MMW Fortschritte der Medizin, 2009, Sep-10, Volume: 151, Issue:37

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Female; Humans; Imidazoles; Migraine Disorders; Migraine with Aura; Myocardial Infarction; Piperazines; Quinazolines; Risk Factors; Stroke; Tryptamines

2009
Recurrent myocardial infarction associated with gefitinib therapy.
    Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:1

    Topics: Antineoplastic Agents; Carcinoid Tumor; Gefitinib; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasm Metastasis; Quinazolines

2011
The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats.
    International journal of cardiology, 2013, Jul-15, Volume: 167, Issue:1

    Topics: Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Linagliptin; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Xanthines

2013
Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats.
    Regulatory peptides, 2003, Jun-15, Volume: 114, Issue:1

    Topics: Alkaloids; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cardiotonic Agents; Creatine Kinase; Heart; Indole Alkaloids; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neurons, Afferent; Organ Size; Quinazolines; Rats; Rats, Wistar

2003
Enhanced platelet aggregability in dogs following myocardial infarction.
    Life sciences, 1977, Mar-01, Volume: 20, Issue:5

    Topics: Animals; Blood Platelets; Carrier Proteins; Collagen; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extracellular Matrix Proteins; Glycoproteins; Ligation; Myocardial Infarction; Platelet Aggregation; Quinazolines; Sulfinpyrazone

1977
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Protein Kinase C; Quinazolines; Rabbits; Receptor, Adenosine A1; Receptors, Adrenergic, alpha-1; Staurosporine; Theophylline; Tyramine; Vasodilator Agents

2005
Acute myocardial infarction with lung cancer during treatment with gefitinib: the possibility of gefitinib-induced thrombosis.
    Pathophysiology of haemostasis and thrombosis, 2005, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Female; Gefitinib; Humans; Lung Neoplasms; Myocardial Infarction; Quinazolines; Thrombosis

2005
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Journal of molecular and cellular cardiology, 2006, Volume: 41, Issue:1

    Topics: Animals; Cardiomegaly; Collagen Type III; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Isoproterenol; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphorylation; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Quinazolines; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling

2006
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Basic research in cardiology, 2007, Volume: 102, Issue:4

    Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin

2007
Limitation of infarct size by decrease of afterload with prazosin.
    Acta cardiologica, 1983, Volume: 38, Issue:5

    Topics: Adult; Aged; Aspartate Aminotransferases; Electrocardiography; Female; Hemodynamics; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines

1983
[Hypertensive therapy with prazosin. Concomitant cardiovascular, metabolic and respiratory diseases. Proven facts and potential aspects].
    Fortschritte der Medizin, 1984, Apr-26, Volume: 102, Issue:16

    Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Kidney; Lipids; Myocardial Infarction; Prazosin; Quinazolines; Respiratory Tract Diseases

1984
Prazosin therapy for refractory variant angina.
    American heart journal, 1983, Volume: 105, Issue:2

    Topics: Aged; Angina Pectoris, Variant; Coronary Vasospasm; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines

1983
Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
    Clinical pharmacology and therapeutics, 1982, Volume: 31, Issue:3

    Topics: Adult; Aged; Cardiac Catheterization; Ferricyanides; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Piperazines; Plethysmography, Impedance; Quinazolines; Vasodilator Agents

1982
[Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
    Revista espanola de cardiologia, 1981, Volume: 34, Issue:1

    Topics: Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines

1981
[Vasodilator therapy of pump failure in acute myocardial infarction].
    Cardiology, 1980, Volume: 66 Suppl 2

    Topics: Adult; Aged; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Prazosin; Quinazolines; Vasodilator Agents

1980
[Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
    Cardiology, 1980, Volume: 66 Suppl 2

    Topics: Adult; Aged; Arterioles; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents

1980
Vasodilator therapy in congestive heart failure.
    Annals of the Academy of Medicine, Singapore, 1981, Volume: 10, Issue:4 Suppl

    Topics: Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prazosin; Quinazolines; Vasodilator Agents

1981
Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate.
    International journal of clinical pharmacology, therapy, and toxicology, 1980, Volume: 18, Issue:5

    Topics: Cardiac Output; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Prazosin; Quinazolines; Time Factors; Vascular Resistance

1980
Effects of calcitonin gene-related peptide and BIBN4096BS on myocardial ischemia in anesthetized rats.
    Acta pharmacologica Sinica, 2001, Volume: 22, Issue:7

    Topics: Animals; Calcitonin Gene-Related Peptide; Cardiotonic Agents; Creatine Kinase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Piperazines; Piperidines; Quinazolines; Rats; Rats, Wistar

2001
Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
    American heart journal, 1979, Volume: 98, Issue:4

    Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance

1979
Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    The New England journal of medicine, 1977, Aug-11, Volume: 297, Issue:6

    Topics: Blood Pressure; Cardiac Output; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Plethysmography, Impedance; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents

1977
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease.
    British journal of clinical pharmacology, 1977, Volume: 4, Issue:5

    Topics: Coronary Disease; Hemodynamics; Humans; Male; Myocardial Contraction; Myocardial Infarction; Phosphodiesterase Inhibitors; Piperidines; Quinazolines

1977
The effect of a potent inhibitor of platelet aggregation, BL-3459, on adrenaline-induced myocardial necrosis in beagle dogs.
    European journal of pharmacology, 1976, Volume: 40, Issue:1

    Topics: Animals; Aspirin; Blood Pressure; Disease Models, Animal; Dogs; Epinephrine; Female; Imidazoles; Male; Myocardial Infarction; Necrosis; Phenoxybenzamine; Platelet Aggregation; Propranolol; Quinazolines

1976
[The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
    Vrachebnoe delo, 1989, Issue:12

    Topics: Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Heart; Inosine Diphosphate; Inosine Nucleotides; Isoproterenol; Male; Myocardial Infarction; Myocardium; Pituitary Hormones, Posterior; Quinazolines; Rats; Rats, Inbred Strains

1989
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
    Japanese circulation journal, 1989, Volume: 53, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain

1989
MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:1

    Topics: Acidosis; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Vessels; Dogs; Female; Heart; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Propranolol; Quinazolines; Quinazolinones

1988
The effects of quazodine on myocardial blood flow in developing myocardial infarcts.
    The Journal of pharmacy and pharmacology, 1971, Volume: 23

    Topics: Animals; Blood Pressure; Cardiac Output; Cats; Coronary Circulation; Dogs; Heart Rate; Injections, Intravenous; Myocardial Infarction; Quinazolines

1971
Haemodynamic and coronary effects of quazodine in cats with developing myocardial infarcts.
    The Journal of pharmacy and pharmacology, 1972, Volume: 24, Issue:9

    Topics: Animals; Blood Flow Velocity; Blood Pressure; Body Temperature; Cardiac Output; Cats; Coronary Circulation; Female; Heart Rate; Heart Ventricles; Hemodynamics; Ligation; Male; Myocardial Infarction; Quinazolines; Time Factors; Vascular Resistance

1972